Barclays Issues Positive Forecast for Clorox (NYSE:CLX) Stock Price

Clorox (NYSE:CLX) had its price target increased by Barclays from $85.00 to $86.00 in a research report sent to investors on Tuesday morning,Benzinga reports. They currently have an underweight rating on the stock.

CLX has been the topic of several other research reports. Morgan Stanley cut their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research note on Friday, May 1st. TD Cowen lifted their price objective on Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research report on Tuesday, March 31st. BNP Paribas Exane dropped their price objective on Clorox from $97.00 to $95.00 and set a “neutral” rating for the company in a report on Monday. UBS Group upped their target price on shares of Clorox from $96.00 to $100.00 and gave the company a “neutral” rating in a research report on Thursday, July 16th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $91.00 target price on shares of Clorox in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Reduce” and an average price target of $103.40.

Clorox Stock Performance

Shares of Clorox stock opened at $95.72 on Tuesday. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The firm has a market cap of $11.57 billion, a P/E ratio of 15.54 and a beta of 0.54. The firm has a 50 day simple moving average of $94.87 and a 200 day simple moving average of $103.98. Clorox has a fifty-two week low of $84.70 and a fifty-two week high of $132.03.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business’s revenue for the quarter was up .1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Sell-side analysts predict that Clorox will post 5.52 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Pierre R. Breber purchased 5,000 shares of Clorox stock in a transaction dated Tuesday, May 5th. The shares were acquired at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the transaction, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 0.63% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Clorox

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Clorox by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after buying an additional 514 shares during the period. Woodline Partners LP raised its position in shares of Clorox by 253.7% in the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after acquiring an additional 7,465 shares during the period. Baird Financial Group Inc. boosted its stake in Clorox by 1.7% during the 2nd quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock worth $3,006,000 after acquiring an additional 424 shares during the last quarter. Jump Financial LLC boosted its stake in Clorox by 173.5% during the 2nd quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock worth $1,500,000 after acquiring an additional 7,924 shares during the last quarter. Finally, Bank of Nova Scotia grew its holdings in Clorox by 26.2% during the second quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock valued at $1,938,000 after purchasing an additional 3,352 shares during the period. Institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.